<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126138">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02000674</url>
  </required_header>
  <id_info>
    <org_study_id>2013/CHU/05</org_study_id>
    <secondary_id>2013-001438-16</secondary_id>
    <nct_id>NCT02000674</nct_id>
  </id_info>
  <brief_title>Succinylcholine vs Rocuronium for Prehospital Emergency Intubation</brief_title>
  <acronym>CURASMUR</acronym>
  <official_title>Succinylcholine vs Rocuronium for Prehospital Emergency Intubation : a Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de la Réunion</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Unité de Soutien Méthodologique (CHU de La Réunion)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SAMU de Paris, Hôpital Necker - Enfants Malades</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de la Réunion</source>
  <oversight_info>
    <authority>France: Angence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      All adult patients with spontaneous cardiac activity and requiring tracheal intubation in
      the pre hospital emergency context will be included in order to compare the use of
      succinylcholine vs Rocuronium for prehospital emergency intubation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All adult patients with spontaneous cardiac activity and requiring tracheal intubation in
      the pre hospital emergency context will be included. All intubation will be performed by an
      emergency physician or a nurse specialized in anesthesia. For patients with spontaneous
      cardiac activity, rapid sequence intubation will be performed to allow intubation.

      Comparisons studied will be : Intubation success rate at the first laryngoscopy, glottis
      exposure assessed by Cormack and Lehane classification, difficult intubation rate assessed
      by the Intubation Difficult Score (IDS), the conditions of intubation assessed by the
      Copenhagen score, the need for alternative airway techniques and the immediate post
      intubation complications rate as vomiting, dental trauma, pulmonary inhalation, arterial
      desaturation , hypotension episodes and cardiac arrest occurrence.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>First-pass intubation success rate</measure>
    <time_frame>between 1 hour to 3 hours after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by the proportion of successful intubation in the first laryngoscopy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of difficult intubation</measure>
    <time_frame>between 1 hour to 3 hours after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured by the Intubation Difficulty Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intubation conditions assessment</measure>
    <time_frame>between 1 hour to 3 hours after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>using the Copenhagen score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for alternate airway devices</measure>
    <time_frame>between 1 hour to 3 hours after inclusion</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>early intubation-related complications</measure>
    <time_frame>between 1 hour to 3 hours after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>complications : esophageal intubation, mainstem intubation, vomiting, pulmonary aspiration, dental trauma, bronchospasm or laryngospasm, ventricular tachycardia, arterial desaturation, hypotension, or cardiac arrest</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1300</enrollment>
  <condition>Coma</condition>
  <condition>Major Trauma</condition>
  <condition>Respiratory Distress</condition>
  <condition>Shock</condition>
  <arm_group>
    <arm_group_label>Administration of Succinylcholine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intubation after IV administration of Succinylcholine 1mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Administration of Rocuronium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intubation after IV administration of Rocuronium 1.2 mg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Succinylcholine : 1mg/kg</intervention_name>
    <arm_group_label>Administration of Succinylcholine</arm_group_label>
    <other_name>Suxaméthonium Aguetant®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium : 1.2 mg/kg</intervention_name>
    <arm_group_label>Administration of Rocuronium</arm_group_label>
    <other_name>ESMERON®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients with spontaneous cardiac activity and requiring tracheal
             intubation in the pre hospital emergency context

        Exclusion Criteria:

          -  Patients in cardiac arrest;

          -  Patients under-18s;

          -  Patients under guardianship ;

          -  Pregnancy known;

          -  Patients with cons to one of the following three drugs: rocuronium, succinylcholine,
             sugammadex;

          -  Patients not affiliated to a social security scheme (beneficiary or legal).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Combes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de La Réunion</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier Combes</last_name>
    <phone>02 62 90 60 46</phone>
    <email>x.combes.samu974@chu-reunion.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vanessa Basque</last_name>
    <phone>02 62 35 95 25</phone>
    <email>vanessa.basque@chu-reunion.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de La Réunion</name>
      <address>
        <city>Saint Denis</city>
        <state>La Réunion</state>
        <zip>97405</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Combes</last_name>
      <phone>02 62 90 20 72</phone>
      <email>x.combes.samu974@chu-reunion.fr</email>
    </contact>
    <investigator>
      <last_name>Xavier Combes</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marielle BASTY-GHUYSEN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal BAUDON</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurent CHEN-CHI-SONG</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francois DALTROFF</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amelie DARMEDRU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilie FENETRIER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Magali FERRY</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bertrand GUIHARD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nasser LAKEBAL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arnaud MICHALON</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie PREDOUR</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna SALNIKOVA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jerome SUDRIAL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de la Réunion</name>
      <address>
        <city>Saint Pierre</city>
        <state>La Réunion</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Jean Marianne</last_name>
      <email>pierre-jean.marianne-cassou@chu-reunion.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre Jean Marianne</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thibault ADENIS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Perine BOURDIN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hakim CHABANE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas MASSEGUIN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Flore PINEAU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoine POUPEL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrien VAGUE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Avicenne</name>
      <address>
        <city>Bobigny</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric Adnet</last_name>
      <email>frederic.adnet@avc.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charlotte Chollet-Xémard, MD</last_name>
      <email>charlotte.chollet@hmn.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marc Freysz, MD</last_name>
      <email>marc.freysz@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Raymond Poincaré</name>
      <address>
        <city>Garches</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Loeb</last_name>
      <email>thomas.loeb@rpc.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Gonesse</name>
      <address>
        <city>Gonesse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>philippe lakhnati, MD</last_name>
      <email>philippe.lakhnati@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU de Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>eric wiel, MD</last_name>
      <email>eric.wiel@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Marc Jacquet</name>
      <address>
        <city>Melun</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karim tazaroute</last_name>
      <email>karim.tazarourte@ch-melun.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nîmes</name>
      <address>
        <city>Nîmes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xavier Bobbia, MD</last_name>
      <email>xavier.bobbia@chu-nimes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Lariboisière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Papa Gueye, MD</last_name>
      <email>papa.gueye@lrb.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de l'Hôtel-Dieu</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gerald Kierzek, MD</last_name>
      <email>gerald.kierzek@htd.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick Ecollan, MD</last_name>
      <email>patrick.ecollan@psl.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Necker</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benoit Vivien, MD</last_name>
      <email>benoit.vivien@nck.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH René Dubos</name>
      <address>
        <city>Pontoise</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Agnès Ricard-Hibon, MD</last_name>
      <email>agnes.ricard-hibon@ch-pontoise.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Annecy</name>
      <address>
        <city>Pringy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dominique Savary, MD</last_name>
      <email>dsavary@ch-annecy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse - Hôpital PURPAN</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent Bounes, MD</last_name>
      <email>bounes.v@chu-toulouse.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 13, 2014</lastchanged_date>
  <firstreceived_date>October 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tracheal intubation</keyword>
  <keyword>pre hospital emergency</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Succinylcholine</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
